BMO downgrades Biogen, asserts company is spending too much on controversial Alzheimer's drug

Argentina Noticias Noticias

BMO downgrades Biogen, asserts company is spending too much on controversial Alzheimer's drug
Argentina Últimas Noticias,Argentina Titulares

Biogen's new Alzheimer's drug aduhelm saw limited pickup in its first few months on the market.

 

No wonder….

For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him Neal_48 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success

$SAVA coming soon to offer competition

Argentina Últimas Noticias, Argentina Titulares



Render Time: 2025-01-10 11:39:12